Viridian Therapeutics, Inc.

VRDN

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001590750

SEC filings (opens in a new tab)

In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Viridian Therapeutics, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of VRDN: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	179	1	177	−1
Shares	91.0M	681.0K	91.4M	+1.00M (+1.1%)
Value	$1.75B	$13.1M	$1.23B	−$500.6M (−28.9%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Viridian Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to VRDN in Q1 2025
Institution	Shares	Value	% of portfolio
Marshall Wace, LLP	1,084,040	$14.6M	0.02%
Rosalind Advisors, Inc.	595,000	$8.02M	3.91%
Nuveen, LLC	248,628	$3.35M	0.00%
Exome Asset Management LLC	217,294	$2.93M	2.62%
Point72 Asset Management, L.P.	204,702	$2.76M	0.01%
Susquehanna Fundamental Investments, LLC	177,166	$2.39M	0.04%
Prelude Capital Management, LLC	67,669	$912.2K	0.09%
SummitTX Capital, L.P.	42,066	$567.0K	0.03%
HSBC Holdings PLC	39,452	$526.4K	0.00%
Engineers Gate Manager LP	19,631	$264.6K	0.00%
Virginia Retirement Systems Et Al	18,200	$245.3K	0.00%
Verition Fund Management LLC	17,637	$237.7K	0.00%
CIBC World Markets Corp	16,557	$223.2K	0.00%
EntryPoint Capital, LLC	13,742	$185.2K	0.08%
Virtus Investment Advisers, Inc.	9,129	$123.1K	0.03%
Simplex Trading, LLC	8,412	$113.0K	0.00%
Point72 (DIFC) Ltd	4,773	$64.3K	0.01%
Skopos Labs, Inc.	1,413	$19.0K	0.00%
Clear Street Markets LLC	174	$2.35K	0.00%
Coldstream Capital Management Inc	134	$1.81K	0.00%
Allworth Financial LP	33	$448	0.00%
Stephens Consulting, LLC	25	$337	0.00%
TD Private Client Wealth LLC	18	$243	0.00%
Creative Financial Designs Inc	10	$135	0.00%
Larson Financial Group LLC	8	$108	0.00%
True Wealth Design, LLC	4	$54	0.00%

Sold out (27)

Institutions that held Viridian Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of VRDN in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Cutter Capital Management, LP	628,677	$12.1M
Lord, Abbett & Co. LLC	459,588	$8.81M
Crestline Management, LP	200,857	$3.85M
Balyasny Asset Management LLC	130,721	$2.51M
Trexquant Investment LP	120,065	$2.30M
Silverarc Capital Management, LLC	100,000	$1.92M
Concentric Capital Strategies, LP	88,527	$1.70M
Caption Management, LLC	56,760	$1.09M
Dimensional Fund Advisors LP	55,924	$1.07M
Group One Trading, L.P.	47,995	$920.1K
Soleus Capital Management, L.P.	45,500	$872.2K
Bryce Point Capital, LLC	44,063	$844.7K
Tudor Investment Corp Et Al	38,367	$735.5K
Braidwell LP	34,094	$653.6K
Qube Research & Technologies Ltd	28,809	$552.3K
ExodusPoint Capital Management, LP	25,724	$493.0K
Bayesian Capital Management, LP	25,700	$492.7K
Scientech Research LLC	20,143	$386.1K
Farringdon Capital, Ltd.	17,152	$328.8K
Brevan Howard Capital Management LP	13,473	$258.3K
Corton Capital Inc.	12,702	$243.5K
E Fund Management Co., Ltd.	12,236	$234.6K
Gsa Capital Partners LLP	11,332	$217.0K
Virtus ETF Advisers LLC	3,952	$75.8K
R Squared Ltd	1,340	$25.7K
Parallel Advisors, LLC	10	$192
WealthTrak Capital Management LLC	5	$96

Not filed for Q1 2025 yet (1)

Institutions that held Viridian Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VRDN in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nuveen Asset Management, LLC	681,012	$13.1M